Safety and Efficacy of Bexagliflozin Compared to Placebo as Add-on Therapy to Metformin in Type 2 Diabetes Subjects
Completed · Phase 3 · Has a placebo group
Conditions studied: Type2 Diabetes Mellitus
In brief
The purpose of this study is to investigate the effect of bexagliflozin compared to placebo as an add-on therapy to metformin in lowering hemoglobin A1c (HbA1c) levels in subjects with type 2 diabetes mellitus (T2DM).
Key facts
- Study ID
- NCT03259789
- Run by
- Theracos
- People needed
- 351
- Starts
- 2017-11-28
- Expected to finish
- 2019-01-23
- Last updated by the study team
- 2021-07-07
Who can join
Age: 20 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Clinical Research Site 1232 — Birmingham, Alabama, United States
- Clinical Research Site 1378 — Birmingham, Alabama, United States
- Clinical Research Site 1269 — Foley, Alabama, United States
- Clinical Research Site 1363 — Little Rock, Arkansas, United States
- Clinical Research Site 1381 — Anaheim, California, United States
- Clinical Research Site 1375 — North Hollywood, California, United States
- Clinical Research Site 1365 — Norwalk, California, United States
- Clinical Research Site 1382 — Norwalk, Connecticut, United States
- Clinical Research Site 1372 — Hollywood, Florida, United States
- Clinical Research Site 1362 — Palm Springs, Florida, United States
- Clinical Research Site 1373 — Pembroke Pines, Florida, United States
- Clinical Research Site 1376 — Nampa, Idaho, United States
- Clinical Research Site 1366 — Chicago, Illinois, United States
- Clinical Research Site 1294 — New Orleans, Louisiana, United States
- Clinical Research Site 1374 — St Louis, Missouri, United States
- Clinical Research Site 1370 — Las Vegas, Nevada, United States
- Clinical Research Site 1009 — Berlin, New Jersey, United States
- Clinical Research Site 1037 — Trenton, New Jersey, United States
- Clinical Research Site 1286 — Albuquerque, New Mexico, United States
- Clinical Research Site 1368 — New York, New York, United States
- Clinical Research Site 1275 — The Bronx, New York, United States
- Clinical Research Site 1019 — Portland, Oregon, United States
- Clinical Research Site 1379 — Gonzales, Texas, United States
- Clinical Research Site 1369 — Houston, Texas, United States
- Clinical Research Site 1371 — San Antonio, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.